About
Our purpose: delivering tomorrow’s precision medicines
Over 80% of validated therapeutic targets are intracellular. Developing drugs to target these proteins is challenging due to significant barriers to delivery, such as cell membranes and degradative systems. As a result, current intracellular therapies are primarily limited to small molecule drugs.